These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16740739)

  • 1. Aptamer mediated siRNA delivery.
    Chu TC; Twu KY; Ellington AD; Levy M
    Nucleic Acids Res; 2006 Jun; 34(10):e73. PubMed ID: 16740739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
    Yoo H; Jung H; Kim SA; Mok H
    Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
    Wilner SE; Levy M
    Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
    McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
    Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells.
    Jeong H; Lee SH; Hwang Y; Yoo H; Jung H; Kim SH; Mok H
    Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27863037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.
    Thiel KW; Hernandez LI; Dassie JP; Thiel WH; Liu X; Stockdale KR; Rothman AM; Hernandez FJ; McNamara JO; Giangrande PH
    Nucleic Acids Res; 2012 Jul; 40(13):6319-37. PubMed ID: 22467215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photomodulating Gene Expression by Using Caged siRNAs with Single-Aptamer Modification.
    Zhang L; Chen C; Fan X; Tang X
    Chembiochem; 2018 Jun; 19(12):1259-1263. PubMed ID: 29488297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Polymer Hybridization with DNA and RNA Directs Nanoparticle Loading, Silencing Delivery, and Aptamer Function.
    Zhou Z; Xia X; Bong D
    J Am Chem Soc; 2015 Jul; 137(28):8920-3. PubMed ID: 26138550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells.
    Zhou J; Tiemann K; Chomchan P; Alluin J; Swiderski P; Burnett J; Zhang X; Forman S; Chen R; Rossi J
    Nucleic Acids Res; 2013 Apr; 41(7):4266-83. PubMed ID: 23470998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
    Kruspe S; Giangrande PH
    Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer.
    de Almeida CEB; Alves LN; Rocha HF; Cabral-Neto JB; Missailidis S
    Int J Pharm; 2017 Jun; 525(2):334-342. PubMed ID: 28373101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for siRNA navigation to desired cells.
    Sioud M
    Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
    Catuogno S; Esposito CL; Giangrande PH
    Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boranophosphate siRNA-aptamer chimeras for tumor-specific downregulation of cancer receptors and modulators.
    Shaw BR; Moussa L; Sharaf M; Cheek M; Dobrikov M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):655-6. PubMed ID: 18776550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin.
    Hussain AF; Tur MK; Barth S
    Nucleic Acid Ther; 2013 Jun; 23(3):203-12. PubMed ID: 23544955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.